Headlands Technologies LLC Decreases Stock Position in Chemed Co. (NYSE:CHE)

Headlands Technologies LLC trimmed its position in shares of Chemed Co. (NYSE:CHE) by 73.3% in the 2nd quarter, Holdings Channel reports. The firm owned 212 shares of the company’s stock after selling 582 shares during the period. Headlands Technologies LLC’s holdings in Chemed were worth $115,000 at the end of the most recent reporting period.

Several other hedge funds have also recently added to or reduced their stakes in CHE. Principal Securities Inc. acquired a new stake in shares of Chemed in the fourth quarter valued at about $51,000. Envestnet Portfolio Solutions Inc. raised its holdings in Chemed by 9.4% in the 4th quarter. Envestnet Portfolio Solutions Inc. now owns 1,346 shares of the company’s stock valued at $787,000 after acquiring an additional 116 shares during the last quarter. Vanguard Personalized Indexing Management LLC lifted its stake in Chemed by 55.2% in the 4th quarter. Vanguard Personalized Indexing Management LLC now owns 1,305 shares of the company’s stock worth $763,000 after purchasing an additional 464 shares in the last quarter. Janney Montgomery Scott LLC boosted its holdings in shares of Chemed by 1.2% during the 4th quarter. Janney Montgomery Scott LLC now owns 10,827 shares of the company’s stock worth $6,331,000 after purchasing an additional 125 shares during the last quarter. Finally, Quadrant Capital Group LLC grew its position in shares of Chemed by 32.9% in the fourth quarter. Quadrant Capital Group LLC now owns 206 shares of the company’s stock valued at $120,000 after purchasing an additional 51 shares in the last quarter. 95.85% of the stock is owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

Separately, Royal Bank of Canada lowered their price objective on Chemed from $712.00 to $697.00 and set an “outperform” rating on the stock in a research note on Tuesday, May 21st.

Chemed Price Performance

Shares of CHE stock opened at $574.76 on Monday. The firm’s 50-day moving average is $564.56 and its two-hundred day moving average is $579.29. Chemed Co. has a 12 month low of $497.36 and a 12 month high of $654.62. The company has a market capitalization of $8.70 billion, a PE ratio of 30.93, a price-to-earnings-growth ratio of 2.31 and a beta of 0.44.

Chemed (NYSE:CHE) last issued its quarterly earnings data on Wednesday, July 24th. The company reported $5.47 earnings per share for the quarter, missing the consensus estimate of $5.59 by ($0.12). Chemed had a return on equity of 29.21% and a net margin of 12.88%. The business had revenue of $595.88 million during the quarter, compared to analysts’ expectations of $599.20 million. During the same quarter in the previous year, the company posted $4.71 earnings per share. The company’s revenue was up 7.6% on a year-over-year basis. Sell-side analysts forecast that Chemed Co. will post 21.77 EPS for the current year.

Chemed Increases Dividend

The business also recently disclosed a quarterly dividend, which was paid on Friday, August 30th. Investors of record on Monday, August 12th were issued a $0.50 dividend. This is a positive change from Chemed’s previous quarterly dividend of $0.40. This represents a $2.00 annualized dividend and a yield of 0.35%. The ex-dividend date of this dividend was Monday, August 12th. Chemed’s payout ratio is 10.76%.

Insider Buying and Selling at Chemed

In other news, Director George J. Walsh III sold 200 shares of the business’s stock in a transaction that occurred on Wednesday, August 21st. The shares were sold at an average price of $577.95, for a total value of $115,590.00. Following the sale, the director now directly owns 3,446 shares of the company’s stock, valued at approximately $1,991,615.70. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. In other Chemed news, Director George J. Walsh III sold 200 shares of Chemed stock in a transaction dated Wednesday, August 21st. The stock was sold at an average price of $577.95, for a total value of $115,590.00. Following the completion of the transaction, the director now directly owns 3,446 shares of the company’s stock, valued at approximately $1,991,615.70. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. Also, Director Andrea R. Lindell sold 831 shares of the stock in a transaction dated Friday, August 16th. The stock was sold at an average price of $571.51, for a total transaction of $474,924.81. Following the sale, the director now directly owns 5,725 shares in the company, valued at approximately $3,271,894.75. The disclosure for this sale can be found here. Insiders have sold 6,744 shares of company stock valued at $3,828,231 over the last 90 days. 3.32% of the stock is owned by insiders.

About Chemed

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.